Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms of the Prostate”

2,898 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,898 results

Early research (Phase 1)Looking for participantsNCT07080242
What this trial is testing

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Who this might be right for
Small Cell Lung Cancer Metastatic or Locally AdvancedNeuroendocrine CancerMetastatic or Locally Advanced Neuroendocrine Prostate Cancer+5 more
SystImmune Inc. 120
Not applicableStudy completedNCT00643994
What this trial is testing

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

Who this might be right for
Prostate CancerProstatic CancerProstate Neoplasms+2 more
Accuray Incorporated 379
Not applicableNot Yet RecruitingNCT07105020
What this trial is testing

ICCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00117286
What this trial is testing

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 57
Large-scale testing (Phase 3)Study completedNCT00193856
What this trial is testing

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

Who this might be right for
Prostate Cancer
Trans Tasman Radiation Oncology Group 1,071
Not applicableLooking for participantsNCT06473259
What this trial is testing

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerHormone Sensitive Prostate CancerMetastatic Tumor
Santa Chiara Hospital 3,000
Testing effectiveness (Phase 2)Ended earlyNCT01420861
What this trial is testing

GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
GTx 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03315754
What this trial is testing

Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

Who this might be right for
Localized Prostate Cancer
Steba Biotech S.A. 50
Not applicableStudy completedNCT00242060
What this trial is testing

Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy

Who this might be right for
Elevated PSAProstate Cancer
University Health Network, Toronto
Post-approval studies (Phase 4)Study completedNCT02773251
What this trial is testing

The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery

Who this might be right for
Prostate CancerPostoperative Adhesion
Bucheon St. Mary's Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00151073
What this trial is testing

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

Who this might be right for
Hormone-Refractory Prostate Cancer
University of Michigan Rogel Cancer Center 28
Not applicableUnknownNCT02879851
What this trial is testing

Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ System

Who this might be right for
Cancer of the Prostate
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Study completedNCT00188513
What this trial is testing

Intensity Modulated Radiation Therapy - Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University Health Network, Toronto 267
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07363486
What this trial is testing

Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Fujian Medical University 9
Post-approval studies (Phase 4)Looking for participantsNCT05919329
What this trial is testing

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Who this might be right for
Castration Resistant Prostate CancerCastration Sensitive Prostate CancerProstate Adenocarcinoma
OHSU Knight Cancer Institute 80
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)Study completedNCT00964002
What this trial is testing

Efavirenz in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Institut Bergonié 61
Testing effectiveness (Phase 2)Study completedNCT00085228
What this trial is testing

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 116
Load More Results